Free Shipping on All Orders $75 Or More! Ends January 31st.

Your Trusted Brand for Over 35 Years

Health Protocols

Kidney Stones


Adeva MM, Souto G. Diet-induced metabolic acidosis. Clinical nutrition (Edinburgh, Scotland). Aug 2011;30(4):416-421.

Aggarwal KP, Narula S, Kakkar M, Tandon C. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. BioMed research international. 2013;2013:292953.

AHA. American Heart Association. Conditions: About Metabolic Syndrome. Available at Last updated 05/14/2014. Accessed 06/01/15.

Ahmadi F, Etemadi SM, Lessan-Pezeshki M, Mahdavi-Mazdeh M, Ayati M, Mir A, Yazdi HR. Contribution of stone size to chronic kidney disease in kidney stone formers. Int J Urol. Jan 2015;22(1):104-108.

Ahmed MH, Barakat S, Almobarak AO. The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome. Renal failure. Jul 2014;36(6):957-962.

Aliotta PJ, Alvero R. Ferri's Clinical Advisor. Urolithiasis (Nephrolithiasis). Available at: Copyright 2015. Accessed 4/10/2015.

Antonelli J, Maalouf N. ePocrates. Nephrolithiasis. Available at: Accessed 4/7/2015.

Arrabal-Polo MA, Arias-Santiago S, de Haro-Munoz T, Lopez-Ruiz A, Orgaz-Molina J, Gonzalez-Torres S, . . . Arrabal-Martin M. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis. Urology. Apr 2013;81(4):731-737.

Arrabal-Polo MA, Arrabal-Martin M, Garrido-Gomez J. Calcium renal lithiasis: metabolic diagnosis and medical treatment. Sao Paulo medical journal = Revista paulista de medicina. 2013;131(1):46-53.

Arrabal-Polo MA, Sierra Giron-Prieto M, Orgaz-Molina J, Zuluaga-Gomez A, Arias-Santiago S, Arrabal-Martin M. Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis. Actas Urol Esp. Jun 2013;37(6):362-367.

Assimos DG. Vitamin C supplementation and urinary oxalate excretion. Reviews in urology. Summer 2004;6(3):167.

Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected by ultrasound. Clinical journal of the American Society of Nephrology: CJASN. Mar 2009;4(3):680-684.

Bantle JP. Dietary fructose and metabolic syndrome and diabetes. The Journal of nutrition. Jun 2009;139(6):1263S-1268S.

Berg C, Larsson L, Tiselius HG. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation. J Urol. Sep 1992;148(3 Pt 2):979-985.

Bianchi G, Giusti A, Pioli G, Barone A, Palummeri E, Girasole G. Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug. Therapeutic advances in musculoskeletal disease. Feb 2010;2(1):29-35.

Bijarnia RK, Kaur T, Aggarwal K, Singla SK, Tandon C. Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. Jun 2008;46(6):2274-2278.

Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. Mar 1996;155(3):839-843.

Borghi L, Meschi T, Maggiore U, Prati B. Dietary therapy in idiopathic nephrolithiasis. Nutrition reviews. Jul 2006;64(7 Pt 1):301-312.

Boza JJ, Moennoz D, Bournot CE, Blum S, Zbinden I, Finot PA, Ballevre O. Role of glutamine on the de novo purine nucleotide synthesis in Caco-2 cells. European journal of nutrition. Feb 2000;39(1):38-46.

Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, . . . De Simone C. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney international. Sep 2001;60(3):1097-1105.

Candelas G, Martinez-Lopez JA, Rosario MP, Carmona L, Loza E. Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review. Clinical and experimental rheumatology. Nov-Dec 2012;30(6):954-961.

Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia. Sep 2009;81(3):182-187.

Chines A, Boniface A, McAlister W, Whyte M. Hypercalciuria in osteogenesis imperfecta: a follow-up study to assess renal effects. Bone. Mar 1995;16(3):333-339.

Cleveland Clinic. Kidney Stones: Oxalate-Controlled Diet. Copyright 2015. Accessed 8/12/2015.

Coe F. The University of Chicago. Why 24 Hour Urine: Supersaturation. Accessed 7/31/2015.

Curhan G, Goldman L (ed.), SchaferAI  (ed.). Goldman's Cecil Medicine, Twenty-Fourth Edition. Chapter 128: Nephrolithiasis; 789-794. Copyright 2012 Saunders, an imprint of Elsevier, Inc. Available at: Accessed: 4/10/2015.

Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Archives of internal medicine. Apr 26 2004;164(8):885-891.

Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. Apr 1 1997;126(7):497-504.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. Journal of the American Society of Nephrology : JASN. Apr 1999;10(4):840-845.

Davalos M, Konno S, Eshghi M, Choudhury M. Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: a possible role of oxidative stress in nephrolithiasis. Journal of endourology / Endourological Society. Mar 2010;24(3):339-345.

del Valle EE, Spivacow FR, Negri AL. [Citrate and renal stones]. Medicina (B Aires). 2013;73(4):363-368.

Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, Prapaipanich S, Ingsathit A, Rajatanavin R. Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney international. May 2004;65(5):1835-1841.

Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. Jun 2010;183(6):2244-2248.

Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM, Jr. High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology. Oct 2012;80(4):780-783.

Escribano J, Balaguer A, Roque i Figuls M, Feliu A, Ferre N. Dietary interventions for preventing complications in idiopathic hypercalciuria. The Cochrane database of systematic reviews. 2014;2:CD006022.

Espinosa E, Murray T. Chapter 184: Kidney Stones (Renal Calculi, Nephrolithiasis). In: Textbook of Natural Medicine, 4th ed. Pizzorno JE, Murray MT (eds.). Copyright 2012 Churchill Livingstone, An Imprint of Elsevier.

Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. Dec 1997;158(6):2069-2073.

Ettinger AS, Lamadrid-Figueroa H, Mercado-Garcia A, Kordas K, Wood RJ, Peterson KE, . . . Tellez-Rojo MM. Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican women. Nutrition journal. 2014;13(1):116.

Fallon B. University of Iowa Hospitals & Clinics. Health Library page. Kidney Stones. Copyright 2015. Accessed 7/31/2015.

Fan J, Shen SJ. The role of Tamm-Horsfall mucoprotein in calcium oxalate crystallization. N-acetylcysteine--a new therapy for calcium oxalate urolithiasis. Br J Urol. Sep 1994;74(3):288-293.

Fenton TR, Lyon AW. Milk and acid-base balance: proposed hypothesis versus scientific evidence. Journal of the American College of Nutrition. Oct 2011;30(5 Suppl 1):471s-475s.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clinical journal of the American Society of Nephrology : CJASN. Aug 2013;8(8):1389-1395.

Ferraz RR, Marques NC, Froeder L, Menon VB, Siliano PR, Baxmann AC, Heilberg IP. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients. Urological research. Apr 2009;37(2):95-100.

Fishman AI, Green D, Lynch A, Choudhury M, Eshghi M, Konno S. Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation. Urology. Aug 2013;82(2):489 e481-487.

Frassetto L, Kohlstadt I. Treatment and prevention of kidney stones: an update. American family physician. Dec 1 2011;84(11):1234-1242.

Friedlander JI, Antonelli JA, Pearle MS. Diet: from food to stone. World J Urol. Feb 2015;33(2):179-185.

Garg A, Bonanome A, Grundy SM, Unger RH, Breslau NA, Pak CY. Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus. The Journal of clinical endocrinology and metabolism. Apr 1990;70(4):1007-1013.

Gasser RW. Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med Wochenschr. Sep 2013;163(17-18):397-402.

Gerster H. No contribution of ascorbic acid to renal calcium oxalate stones. Annals of nutrition & metabolism. 1997;41(5):269-282.

Gettman MT, Segura JW. Struvite stones: diagnosis and current treatment concepts. Journal of endourology / Endourological Society. Nov 1999;13(9):653-658.

Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG. Urine citrate and renal stone disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. Aug 1 1989;141(3):217-221.

Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clinical journal of the American Society of Nephrology : CJASN. Jul 2007;2(4):745-749.

Graham HN. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine. 5// 1992;21(3):334-350.

Grases F, Prieto RM, Gomila I, Sanchis P, Costa-Bauza A. Phytotherapy and renal stones: the role of antioxidants. A pilot study in Wistar rats. Urological research. Feb 2009;37(1):35-40.

Grassi W, De Angelis R. Clinical features of gout. Reumatismo. 2011;63(4):238-245.

Grover A, LeBoff M. Osteoporosis: Prevention and Treatment. In: ENDOTEXT [Internet] De Groot LJ, Beck-Peccoz P, Chrousos G, et al, eds. South Dartmouth (MA):, Inc. Last updated 3/22/2013.

Gul Z, Monga M. Medical and dietary therapy for kidney stone prevention. Korean journal of urology. Dec 2014;55(12):775-779.

Halabe A, Sperling O. Uric acid nephrolithiasis. Mineral and electrolyte metabolism. 1994;20(6):424-431.

Haleblian GE, Leitao VA, Pierre SA, Robinson MR, Albala DM, Ribeiro AA, Preminger GM. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis. Journal of endourology / Endourological Society. Jun 2008;22(6):1359-1366.

Hartman C, Friedlander JI, Moreira DM, Elsamra SE, Smith AD, Okeke Z. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus. BJU Int. Apr 2015;115(4):619-624.

Healy KA, Hubosky SG, Bagley DH. 24-Hour Urine Collection in the Metabolic Evaluation of Stone Formers: Is One Study Adequate? Journal of Endourology. 2012;27(3):374-378.

Heaney RP. Calcium supplementation and incident kidney stone risk: a systematic review. Journal of the American College of Nutrition. Oct 2008;27(5):519-527.

Heilberg IP, Goldfarb DS. Optimum nutrition for kidney stone disease. Advances in chronic kidney disease. Mar 2013;20(2):165-174.

Heseltine D, Bramble MG. Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly. Current medical research and opinion. 1988;11(4):232-235.

Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Sep 1998;13(9):2241-2247.

Higdon J. Linus Pauling Institute. Micronutrient Information Center. Potassium. Last updated 12/2010. Accessed 8/6/2015.

Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, . . . Milliner D. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Nov 2011;26(11):3609-3615.

Huang HS, Chen J, Chen CF, Ma MC. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney international. Aug 2006;70(4):699-710.

Husain A, Madhesia D. Heterocyclic compounds as carbonic anhydrase inhibitor. Journal of enzyme inhibition and medicinal chemistry. Dec 2012;27(6):773-783.

Ishikawa T, Aw W, Kaneko K. Metabolic Interactions of Purine Derivatives with Human ABC Transporter ABCG2: Genetic Testing to Assess Gout Risk. Pharmaceuticals (Basel, Switzerland). 2013;6(11):1347-1360.

Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol. Jan 2005;173(1):271-275.

Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, . . . Sriboonlue P. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. Mar 2004;87(3):255-263.

Jeong BC, Kim BS, Kim JI, Kim HH. Effects of green tea on urinary stone formation: an in vivo and in vitro study. Journal of endourology / Endourological Society. May 2006;20(5):356-361.

Johns Hopkins. Johns Hopkins Health Library. Kidney Stones.,P01494/. Accessed 7/17/2015.

Kanbara A, Hakoda M, Seyama I. Urine alkalization facilitates uric acid excretion. Nutrition journal. 2010;9:45.

Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. Apr 2007;177(4):1358-1362; discussion 1362; quiz 1591.

Karagulle O, Smorag U, Candir F, Gundermann G, Jonas U, Becker AJ, . . . Gutenbrunner C. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis. World J Urol. Jun 2007;25(3):315-323.

Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hori J, Wada N, Hou K. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology. Jan 2004;63(1):7-11; discussion 11-12.

Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. Journal of the American Society of Nephrology : JASN. Jun 2008;19(6):1197-1203.

Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;2014:943162.

Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Current opinion in nephrology and hypertension. Jul 2013;22(4):390-396.

Kenny JE, Goldfarb DS. Update on the pathophysiology and management of uric acid renal stones. Curr Rheumatol Rep. Apr 2010;12(2):125-129.

Kim YN, Cho YO. Evaluation of vitamin B6 intake and status of 20- to 64-year-old Koreans. Nutrition research and practice. Dec 2014;8(6):688-694.

Knight J, Deora R, Assimos DG, Holmes RP. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis. Jun 2013;41(3):187-196.

Koeppen BM. The kidney and acid-base regulation. 2009;33(4):275-281.

Kohri K, Garside J, Blacklock NJ. The role of magnesium in calcium oxalate urolithiasis. Br J Urol. Feb 1988;61(2):107-115.

Krambeck AE, Khan NF, Jackson ME, Lingeman JE, McAteer JA, Williams JC, Jr. Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones. J Urol. Oct 2010;184(4):1543-1549.

Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, . . . Bushinsky DA. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. Journal of the American Society of Nephrology. April 8, 2015.

Kristensen C, Parks JH, Lindheimer M, Coe FL. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney international. Nov 1987;32(5):749-753.

Kwak C, Kim HK, Kim EC, Choi MS, Kim HH. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. European urology. Oct 2003;44(4):475-481.

LabCorp. LabCorp website: Test Menu: Kidney Stone Urine Test Combination With Saturation Calculations. Accessed 6/25/2015.

Lambert E, Arunachalam D. First Consult. Nephrolithiasis. Available at: Copyright Elsevier BV, Inc. Last updated 7/12/2012. Accessed 4/10/2015.

Lasram MM, Dhouib IB, El Fazaa S, Gharbi N. A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development. Clin Biochem. Apr 25 2015.

Lewis JL. Merck Manual. Professional Version. Acid-Base Regulation. Last updated 2/2013. Accessed 7/31/2015.

Li H, Klett DE, Littleton R, Elder JS, Sammon JD. Role of insulin resistance in uric acid nephrolithiasis. World J Nephrol. Nov 6 2014;3(4):237-242.

Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney international. Sep 2005;68(3):1244-1249.

Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney international. Dec 2010;78(11):1178-1185.

Maalouf NM. Metabolic syndrome and the genesis of uric acid stones. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. Jan 2011;21(1):128-131.

Marangella M, Vitale C, Bagnis C, Petrarulo M, Tricerri A. Use of drugs for nephrolithiasis. Clin Cases Miner Bone Metab. May 2008;5(2):131-134.

Martini LA, Heilberg IP. Stop dietary calcium restriction in kidney stone-forming patients. Nutrition reviews. Jul 2002;60(7 Pt 1):212-214.

Massey LK. Dietary influences on urinary oxalate and risk of kidney stones. Front Biosci. May 1 2003;8:s584-594.

Massey L. Magnesium therapy for nephrolithiasis. Magnes Res. 2005;18(2):123-6.

Mayo Clinic. Patient Care & Health Info page. Nutrition and healthy eating. Gout diet: What's allowed, what's not. 4/11/2015a. Accessed 6/18/2015.

Mayo Clinic. Diseases and Conditions: Kidney Stones. Available at Last updated 02/26/2015b. Accessed 05/04/2015. 2015.

Miller AW, Dearing D. The metabolic and ecological interactions of oxalate-degrading bacteria in the Mammalian gut. Pathogens. 2013;2(4):636-652.

Mitwalli A, Ayiomamitis A, Grass L, Oreopoulos DG. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones. International urology and nephrology. 1988;20(4):353-359.

Moe SM. Disorders involving calcium, phosphorus, and magnesium. Primary care. Jun 2008;35(2):215-237, v-vi.

Mogna L, Pane M, Nicola S, Raiteri E. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? Journal of clinical gastroenterology. Nov-Dec 2014;48 Suppl 1:S91-95.

Morris RC, Jr., Schmidlin O, Tanaka M, Forman A, Frassetto L, Sebastian A. Differing effects of supplemental KCl and KHCO3: pathophysiological and clinical implications. Seminars in nephrology. Sep 1999;19(5):487-493.

Morton AR, Iliescu EA, Wilson JW. Nephrology: 1. Investigation and treatment of recurrent kidney stones. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. Jan 22 2002;166(2):213-218.

Murphy C, Murphy S, O'Brien F, O'Donoghue M, Boileau T, Sunvold G, . . . O'Mahony L. Metabolic activity of probiotics-oxalate degradation. Vet Microbiol. Apr 14 2009;136(1-2):100-107.

Murthy MS, Farooqui S, Talwar HS, Thind SK, Nath R, Rajendran L, Bapna BC. Effect of pyridoxine supplementation on recurrent stone formers. Int J Clin Pharmacol Ther Toxicol. Sep 1982;20(9):434-437.

Napoli N, Thompson J, Civitelli R, Armamento-Villareal RC. Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density. The American journal of clinical nutrition. May 2007;85(5):1428-1433.

Nath R, Thind SK, Murthy MSR, Farooqui S, Gupta R, Koul HK. Role of Pyridoxine in Oxalate Metabolism. Annals of the New York Academy of Sciences. 1990;585(1):274-284.

Nazzal L, Puri S, Goldfarb DS. Enteric hyperoxaluria: an important cause of end-stage kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Feb 20 2015.

Negri AL, Spivacow FR, Del Valle EE. [Diet in the treatment of renal lithiasis. Pathophysiological basis]. Medicina (B Aires). 2013;73(3):267-271.

Ngo TC, Assimos DG. Uric Acid nephrolithiasis: recent progress and future directions. Reviews in urology. Winter 2007;9(1):17-27.

Ni Y, Eng C. Vitamin E protects against lipid peroxidation and rescues tumorigenic phenotypes in cowden/cowden-like patient-derived lymphoblast cells with germline SDHx variants. Clinical cancer research : an official journal of the American Association for Cancer Research. Sep 15 2012;18(18):4954-4961.

Nicar MJ, Hill K, Pak CY. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. Jun 1987;2(3):215-220.

NIDDK. National Institute of Diabetes and Digestive and Kidney Dseases. National Institutes of Health: Health nformaton: The Kidneys and How They Work. Available at Last updated 05/21/2014. Accessed 05/25/2015.

NIH. National Institutes of Health: National Institute of Diabetes and Digestive and Kidney Diseases: The Urinary Tract and How it Works. Available at Last updated 01/22/2014. Accessed 04/20/15.

NLM. National Library of Medicine. Kidney Stones (Renal Calculi). Accessed 7/17/2015.

NLM. US National Library of Medicine. Daily Med: Cuprimine. Available at Last updated 08/2012. Accessed 06/01/2015.

Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, . . . Basiri A. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. American journal of kidney diseases : the official journal of the National Kidney Foundation. Mar 2014;63(3):456-463.

Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, . . . Borghi L. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. The American journal of clinical nutrition. Mar 2010;91(3):565-570.

Nussey S, Whitehead S. Endocrinology: An Integrated Approach. Oxford: BIOS Scientific Publishers; 2001.

Okombo J, Liebman M. Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects. Urological research. Jun 2010;38(3):169-178.

PAMF. Palo Alto Medical Foundation. Gout: Preventing Gout Attacks. Last updated 12/2010. Accessed 6/18/2015.

Pak CY, Sakhaee K, Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney international. Sep 1986;30(3):422-428.

Park HK, Jeong BC, Sung MK, Park MY, Choi EY, Kim BS, . . . Kim JI. Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioflavonoid quercetin. J Urol. Apr 2008;179(4):1620-1626.

Pena de la Vega L, Lieske JC, Milliner D, Gonyea J, Kelly DG. Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN. Journal of parenteral and enteral nutrition. Nov-Dec 2004;28(6):435-438.

Portis AJ, Sundaram CP. Diagnosis and initial management of kidney stones. American family physician. Apr 1 2001;63(7):1329-1338.

Preminger GM. Merck Manual. Professional Version. Urinary Calculi. Copyright 2015. Accessed 6/18/2015.

Prien EL, Sr., Gershoff SF. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi. J Urol. Oct 1974;112(4):509-512.

Princen HM, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Poppel G, Gevers Leuven JA, van Hinsbergh VW. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arteriosclerosis, thrombosis, and vascular biology. Mar 1995;15(3):325-333.

Rodgers A. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation. Journal of the American Society of Nephrology : JASN. Nov 1999;10 Suppl 14:S351-354.

Rodgers AL. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int. 1997;58(2):93-99.

Rodgers AL. The influence of South African mineral water on reduction of risk of calcium oxalate kidney stone formation. S Afr Med J. Apr 1998;88(4):448-451.

Rohlfing JJ, Brunzell JD. The effects of diuretics and adrenergic-blocking agents on plasma lipids. The Western journal of medicine. Aug 1986;145(2):210-218.

Ruml LA, Dubois SK, Roberts ML, Pak CY. Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. Apr 1995;10(4):655-662.

Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacology & therapeutics. Feb 2014;141(2):150-159.

Sakhaee K, Griffith C, Pak CY. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg Obes Relat Dis. Jan-Feb 2012;8(1):67-72.

Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Seminars in nephrology. Mar 2008;28(2):174-180.

Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. The Journal of clinical endocrinology and metabolism. Jun 2012;97(6):1847-1860.

Sakhaee K, Poindexter JR, Griffith CS, Pak CY. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. The Journal of urology. Sep 2004;172(3):958-961.

Sands JM, Layton HE. The physiology of urinary concentration: an update. Seminars in nephrology. May 2009;29(3):178-195.

Sarig S. The hyperuricosuric calcium oxalate stone former. Mineral and electrolyte metabolism. 1987;13(4):251-256.

Schwalfenberg GK. The Alkaline Diet: Is There Evidence That an Alkaline pH Diet Benefits Health? Journal of Environmental and Public Health. 2012;2012:727630.

Shekarriz B, Lu HF, Stoller ML. Correlation of unilateral urolithiasis with sleep posture. J Urol. Apr 2001;165(4):1085-1087.

Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol. Oct 2001;166(4):1487-1491.

Siener R, Jahnen A, Hesse A. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. European journal of clinical nutrition. Feb 2004;58(2):270-276.

Siener R, Jansen B, Watzer B, Hesse A. Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation. J Urol. Feb 2011;185(2):719-724.

Singh KJ, Kaur J. Comparison of three different endoscopic techniques in management of bladder calculi. Indian journal of urology : IJU : journal of the Urological Society of India. Jan 2011;27(1):10-13.

Sloand JA, Izzo JL, Jr. Captopril reduces urinary cystine excretion in cystinuria. Archives of internal medicine. Aug 1987;147(8):1409-1412.

Sorensen MD, Eisner BH, Stone KL, Kahn AJ, Lui LY, Sadetsky N, Stoller ML. Impact of calcium intake and intestinal calcium absorption on kidney stones in older women: the study of osteoporotic fractures. The Journal of urology. Apr 2012;187(4):1287-1292.

Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, . . . Stoller ML. Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women's Health Initiative report. J Urol. Dec 2014;192(6):1694-1699.

Sorensen MD, Kahn AJ, Reiner AP, Tseng TY, Shikany JM, Wallace RB, . . . Stoller ML. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol. May 2012;187(5):1645-1649.

Stitchantrakul W, Sopassathit W, Prapaipanich S, Domrongkitchaiporn S. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake. Southeast Asian J Trop Med Public Health. Dec 2004;35(4):1028-1033.

Suresh E, Pazianas M, Abrahamsen B. Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford, England). Jan 2014;53(1):19-31.

Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney international. Jan 2008;73(2):207-212.

Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. Journal of the American Society of Nephrology : JASN. Oct 2009;20(10):2253-2259.

Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. Journal of the American Society of Nephrology : JASN. Dec 2004;15(12):3225-3232.

Thamilselvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int. Jul 2005;96(1):117-126.

Thamilselvan V, Menon M, Thamilselvan S. Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of alpha-tocopherol and ascorbic acid. BJU Int. Jul 2014;114(1):140-150.

Thom JA, Morris JE, Bishop A, Blacklock NJ. The influence of refined carbohydrate on urinary calcium excretion. British journal of urology. Dec 1978;50(7):459-464.

Tiselius HG. Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int. Jul 2001;88(2):158-168.

Torricelli FC, De S, Gebreselassie S, Li I, Sarkissian C, Monga M. Type-2 diabetes and kidney stones: impact of diabetes medications and glycemic control. Urology. Sep 2014;84(3):544-548.

Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, . . . Pearle MS. Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol. Jul 2014;192(1):137-141.

Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. Aug 2003;170(2 Pt 1):397-401.

Traxer O, Pearle MS, Gattegno B, Thibault P. [Vitamin C and stone risk. Review of the literature]. Prog Urol. Dec 2003;13(6):1290-1294.

Trinchieri A. Diet and renal stone formation. Minerva medica. Feb 2013;104(1):41-54.

Trinchieri A, Boccafoschi C, Chisena S, De Angelis M, Seveso M. [Study of the diuretic efficacy and tolerability of therapy with Rocchetta mineral water in patients with recurrent calcium kidney stones]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia. Apr 1999;71(2):121-124.

Trinchieri A, Lizzano R, Bernardini P, Nicola M, Pozzoni F, Romano AL, . . . Confalanieri S. Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation. Dig Liver Dis. Sep 2002;34 Suppl 2:S160-163.

UCKSETP. University of Chicago Kidney Stone Evaluation and Treatment Program. Overview: Kidney Stone Causes, Treatment and Prevention. Copyright 2015. Accessed 9/16/2015.

UMICH. University of Michigan. Dietary Changes to Prevent Calcium Oxalate Stones. Accessed 7/31/2015.

UMMC. University of Maryland Medical Center. Health Information: Medical Reference Guide: Kidney Stones. Available at Last updated 06/25/2013. Accessed 04/20/15.

UMMC. University of Maryland Medical Center. Medical Reference Guide: Animation Pages: Kidney Stones. Available at: Last updated 4/14/2014. Accessed 4/14/2015.

Vicentini FC, Gomes CM, Danilovic A, Neto EA, Mazzucchi E, Srougi M. Percutaneous nephrolithotomy: Current concepts. Indian journal of urology : IJU : journal of the Urological Society of India. Jan 2009;25(1):4-10.

Wong YV, Cook P, Somani BK. The association of metabolic syndrome and urolithiasis. International journal of endocrinology. 2015;2015:570674.

Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert opinion on pharmacotherapy. Mar 2013;14(4):435-447.

Yamaoka T, Itakura M. [Metabolism of purine nucleotides and the production of uric acid]. Nihon rinsho. Japanese journal of clinical medicine. Dec 1996;54(12):3188-3194.

Yasui T, Tanaka H, Fujita K, Iguchi M, Kohri K. Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. European urology. May 2001;39(5):580-585.

Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol. Jun 2007;177(6):2179-2184.

Zhai W, Zheng J, Yao X, Peng B, Liu M, Huang J, . . . Xu Y. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat. BMC complementary and alternative medicine. 2013;13:228.

Zhang F, Lau SS, Monks TJ. The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis. Toxicological sciences : an official journal of the Society of Toxicology. Mar 2011;120(1):87-97.

Zhu W, Xu YF, Feng Y, Peng B, Che JP, Liu M, Zheng JH. Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model. Urolithiasis. Dec 2014;42(6):519-526.

Ziaee SA, Moradi A, Fateh M, Moghaddam SM. Sleep posture and unilateral renal stone formation. Scand J Urol Nephrol. 2008;42(6):551-554.

Zimmermann DJ, Voss S, von Unruh GE, Hesse A. Importance of magnesium in absorption and excretion of oxalate. Urol Int. 2005;74(3):262-267.

Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol. 2009;11(3):134-44.

Zwolinska D, Medynska A, Kilis-Pstrusinska K. [Hyperuricosuria in children]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. Apr 2000;8(46):179-180.